| Direct interaction between the PRDM3 and PRDM16 tumor suppressors and the NuRD chromatin remodeling complex D Ivanochko, L Halabelian, E Henderson, P Savitsky, H Jain, E Marcon, ... Nucleic acids research 47 (3), 1225-1238, 2019 | 43 | 2019 |
| Degradation of GSPT1 causes TP53-independent cell death in leukemia while sparing normal hematopoietic stem cells RS Sellar, AS Sperling, M Słabicki, JA Gasser, ME McConkey, ... The Journal of Clinical Investigation 132 (16), 2022 | 32 | 2022 |
| Harnessing citizen science through mobile phone technology to screen for immunohistochemical biomarkers in bladder cancer P Smittenaar, AK Walker, S McGill, C Kartsonaki, RJ Robinson-Vyas, ... British journal of cancer 119 (2), 220-229, 2018 | 15 | 2018 |
| The emerging role of targeted protein degradation to treat and study cancer MH Brodermann, EK Henderson, RS Sellar The Journal of Pathology, 2024 | 4 | 2024 |
| Evaluation of linker length effects on a BET bromodomain probe R Traquete, E Henderson, S Picaud, PMSD Cal, F Sieglitz, T Rodrigues, ... Chemical Communications 55 (68), 10128-10131, 2019 | 4 | 2019 |
| Enhancing selectivity and overcoming tissue-specific toxicity in drug discovery: A novel BET inhibitor with targeted delivery for prostate cancer treatment C Tang, R Traquete, E Henderson, J Conde, S Picaud, P Filippakopoulos, ... Cancer Research 84 (6_Supplement), 5779-5779, 2024 | | 2024 |
| The role of BET attenuation in melanoma EK Henderson University of Oxford, 2020 | | 2020 |
| BET mechanisms in cancer E Henderson, P Filippakopoulos Histone Modifications in Therapy, 101-142, 2020 | | 2020 |
